Neuroinflammation is inflammation within the nervous system and includes activation of immune cells (particularly microglia) and non-immune cells, as well as increases in inflammatory mediators (including cytokines.) It has long been known that production of cytokines is increased in the brain following traumatic brain injury.
A recent paper adds to the continuing stream of research correlating poor recovery from traumatic brain injury and increased levels of inflammatory cytokines. This persistent inflammatory state within the brain is responsible for the persistence of symptoms after a brain injury, as well as similar symptoms found in patients without a history of head injury – such as patients with depression or PTSD.
The Autonomic Advantage Brain Recovery Program is the most effective approach to reducing neuroinflammation, and can halts symptoms such as headache, irritability, depression, sleep disturbance, fatigue, dizziness and memory impairment.